Sigma Planning Corp Rocket Pharmaceuticals, Inc. Transaction History
Sigma Planning Corp
- $3.16 Billion
- Q2 2024
A detailed history of Sigma Planning Corp transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 24,905 shares of RCKT stock, worth $399,974. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,905
Previous 25,480
2.26%
Holding current value
$399,974
Previous $686,000
21.87%
% of portfolio
0.02%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding RCKT
# of Institutions
196Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$284 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$147 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$99.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$93.3 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$69.5 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.22B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...